Status:
UNKNOWN
Epidemiological, Clinical and Biological Caracteristics of Patients Presenting With Invasive Meningococcal Disease
Lead Sponsor:
Poitiers University Hospital
Conditions:
Meningococcal Infections
Eligibility:
All Genders
Brief Summary
An unusual increase in cases of invasive meningococcal infection between late 2022 and early 2023. These cases sometimes had atypical presentations (large numbers of bacteremias without meningitis). T...
Detailed Description
Invasive meningococcal disease (IMD) accounts for a small number of cases (500-600 cases/year) in mainland France. Despite advances in its management, the disease is still associated with a 10-20% mor...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Clinical diagnosis of Invasive Meningococcal infection (defined by the isolation of Neisseria meningitis in a normaly steril site (CSL, blood, articulation, ..) by PCR or culture.
- No exclusion Criteria
Exclusion
Key Trial Info
Start Date :
June 30 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05981599
Start Date
June 30 2023
End Date
September 30 2023
Last Update
August 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Poitiers University
Poitiers, Vienne, France, 86000